[DIV28SUPER] Accepted Posters at the 2014 CPA Conference

 

 

Trouble viewing this email? Visit our Website   ACCEPTED POSTERS New research and practices in addiction psychology will be presented as part of the 39 posters selected to be presented at the 2014 Collaborative Perspectives on Addiction Conference. See attached to view the list of selected posters.     2014 Collaborative Perspectives on Addiction Atlanta, Georgia Feb. 28 - March 1, 2014 Reserve Your Hotel | Conference Registration | Present a Poster Download Registration Brochure Earlybird Registration Ends January 17 Last Day to Book Your Hotel is January 29     ABOUT THE CONFERENCE   The theme for the 2014 CPA is "Changing Addictive Behavior: Bench to Bedside and Back Again" ·       Thought-provoking keynotes and cross-discipline panels ·       Interactive environment for collaboration/networking ·       Pre-Conference Workshop (see below) ·       Pre-Conference “Functional Integration” Session (see below) ·       Poster Sessions ·       Discounted rates for Early Career Psychologists ·       Student opportunities (discounted rates, special networking, etc.) ·       You don't have to be a member of either division or APA to attend the conference! ·       CE is available*!   MEET THE KEYNOTERS   SANDRA A. BROWN, PHD is Vice Chancellor for Research and a Distinguished Professor of Psychology and Psychiatry at the University of California, San Diego. Dr. Brown is internationally recognized for her developmentally focused alcohol and drug intervention research. She is the past President of Division 50 (Addictions) of the American Psychological Association, is on the executive board of numerous scientific organizations, and has over 320 publications. She is involved in addiction prevention and intervention at the regional, state, and national levels and helped lead NIAAA’s effort to establish national screening guidelines for youth. She currently directs the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA).   MICHAEL A. NADER, PHD is a Professor of Physiology and Pharmacology, Wake Forest University School of Medicine, in Winston-Salem, NC. Dr. Michael Nader’s research interest began in the laboratory of Dr. Alice Young at Wayne State University. He received his Ph.D. in 1985 from the University of Minnesota, under the mentorship of Dr. Travis Thompson and completed post-doctoral training in behavioral pharmacology at Uniformed Services University under the mentorship of Dr. James Barrett. In 1988, he went to the University of Chicago, where Dr. William Woolverton trained him in nonhuman primate models of cocaine abuse. Since 1992, Dr. Nader has been on the faculty in the Department of Physiology and Pharmacology at Wake Forest University School of Medicine, where he is Professor. His research has focused on nonhuman primate models of drug abuse, combining brain imaging with behavioral methods to better understand how environmental (including social) and pharmacological variables influence addiction. His laboratory is the only one in the world studying socially housed monkeys (male and female) in intravenous drug self-administration studies. He has served on Board of Directors of the CPDD, is past-chair of the Division of Behavioral Pharmacology at ASPET and is currently a member of NIDA Council. Dr. Nader has a MERIT Award from NIDA.   NIH FUNCTIONAL MERGER   Key members of NIAAA and NIDA along with established researchers in Division 28 & 50 have been invited to participate in a discussion on the implications of the NIH functional integration of the addiction research portfolio. The goal is to create an open dialog and all researchers are welcome to join in the discussion. Pre-registration is required, but there is no cost to attend. We encourage submission of questions, concerns, or ideas prior to the session. Please email the program co-chairs.  Friday, 9-11 am.     PRE-CONFERENCE WORKSHOP   Treating Adolescent Substance Abuse:  What Works and How Can We Do It? Adolescence is an exciting period of development, as it inherently involves the exploration of identity, autonomy, sexuality, value systems, and peer relationships. Further, during this period, adolescents often “try on” different facets of adult life, including experimentation with health risk behaviors, including alcohol, cigarette, and cannabis use. This experimentation is facilitated by changes in adolescents’ social environment, which becomes increasingly peer-dominated, and has an increasing presence of alcohol and cannabis use opportunities. While many youth continue to adulthood without consequence, the substance use patterns of many adolescents interfere with their academic progress, as well as their health, personal, and social development. This workshop presents an opportunity for us to explore the state of the art of adolescent addictions research, including current empirically supported interventions. In addition, this workshop includes hands-on experience practicing foundational skills in empirically supported intervention approaches (including motivational intervention and contingency management). Participants will depart with basic knowledge of, skills in, and resources to obtain further information in each clinical approach. Presenter: Sarah W. Feldstein Ewing, Ph.D., University of New Mexico, Honors College/Center on Alcoholism, Substance Abuse, and Addictions (CASAA) **This workshop provides 4 CE Credits and pre-registration is required.   POSTER SESSION   Last year’s poster session was the highlight of our networking events. This year, we will also be providing poster awards and inviting the first authors of select posters to present their research at our “Rapid Fire Research” sessions.  The priority deadline for poster submissions has passed, but poster proposals submitted prior to Nov. 30th will be considered.  For information on submitting, visit www.tinyurl.com/2014CPAPosters.   HOTEL/VENUE   The beautiful W Hotel in Midtown Atlanta will be the venue for our Annual Conference. The hotel is located in the heart of Midtown and is local to public transportation. Room rates are $159 per night. Reserve your room now!   MORE INFORMATION   Katie Witkiewitz, PhD, Co-Chair Jennifer Buckman, PhD, Co-Chair Jenna Cohen, Registration and Hotel Accommodations (202-682-5132)       *Continuing Education provided during the Collaborative Perspectives on Addiction Conference is provided by APA Division 50. APA Division 50 is approved by the American Psychological Association to sponsor continuing education for psychologists. Division 50 maintains responsibility for this program and its content. For more information on the available hours and learning objectives, contact jcohen@apa.org.

 

[DIV28SUPER] FW: Register for the Collaborative Perspectives on Addiction Conference!

 

 

Trouble viewing this email? Visit our Website Register for the Collaborative Perspectives on Addiction Conference! The conference will feature experts on the psychology of addictive behavior, including two dynamic keynotes, a pre-conference workshop, several cross-discipline plenaries and symposia, and countless opportunities for networking. Register for the CPA now!   2014 Collaborative Perspectives on Addiction Atlanta, Georgia Feb. 28 - March 1, 2014 Reserve Your Hotel | Conference Registration | Present a Poster Download Registration Brochure Earlybird Registration Ends January 17 Last Day to Book Your Hotel is January 29     ABOUT THE CONFERENCE   The theme for the 2014 CPA is "Changing Addictive Behavior: Bench to Bedside and Back Again" ·       Thought-provoking keynotes and cross-discipline panels ·       Interactive environment for collaboration/networking ·       Pre-Conference Workshop (see below) ·       Pre-Conference “Functional Integration” Session (see below) ·       Poster Sessions ·       Discounted rates for Early Career Psychologists ·       Student opportunities (discounted rates, special networking, etc) ·       You don't have to be a member of either division or APA to attend the conference! ·       CE is available*!   MEET THE KEYNOTERS   SANDRA A. BROWN, PH.D. is Vice Chancellor for Research and a Distinguished Professor of Psychology and Psychiatry at the University of California, San Diego. Dr. Brown is internationally recognized for her developmentally focused alcohol and drug intervention research. She is the past President of Division 50 (Addictions) of the American Psychological Association, is on the executive board of numerous scientific organizations, and has over 320 publications. She is involved in addiction prevention and intervention at the regional, state, and national levels and helped lead NIAAA’s effort to establish national screening guidelines for youth. She currently directs the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA).   MICHAEL A. NADER, PH.D. is a Professor of Physiology and Pharmacology, Wake Forest University School of Medicine, in Winston-Salem, NC. Dr. Michael Nader’s research interest began in the laboratory of Dr. Alice Young at Wayne State University. He received his Ph.D. in 1985 from the University of Minnesota, under the mentorship of Dr. Travis Thompson and completed post-doctoral training in behavioral pharmacology at Uniformed Services University under the mentorship of Dr. James Barrett. In 1988, he went to the University of Chicago, where Dr. William Woolverton trained him in nonhuman primate models of cocaine abuse. Since 1992, Dr. Nader has been on the faculty in the Department of Physiology and Pharmacology at Wake Forest University School of Medicine, where he is Professor. His research has focused on nonhuman primate models of drug abuse, combining brain imaging with behavioral methods to better understand how environmental (including social) and pharmacological variables influence addiction. His laboratory is the only one in the world studying socially housed monkeys (male and female) in intravenous drug self-administration studies. He has served on Board of Directors of the CPDD, is past-chair of the Division of Behavioral Pharmacology at ASPET and is currently a member of NIDA Council. Dr. Nader has a MERIT Award from NIDA.   NIH FUNCTIONAL MERGER   Key members of NIAAA and NIDA along with established researchers in Division 28 & 50 have been invited to participate in a discussion on the implications of the NIH functional integration of the addiction research portfolio. The goal is to create an open dialog and all researchers are welcome to join in the discussion. Pre-registration is required, but there is no cost to attend. We encourage submission of questions, concerns, or ideas prior to the session. Please email the program co-chairs (see page 2).  Friday, 9-11 am.   PRE-CONFERENCE WORKSHOP   Treating Adolescent Substance Abuse:  What Works and How Can We Do It? Adolescence is an exciting period of development, as it inherently involves the exploration of identity, autonomy, sexuality, value systems, and peer relationships. Further, during this period, adolescents often “try on” different facets of adult life, including experimentation with health risk behaviors, including alcohol, cigarette, and cannabis use. This experimentation is facilitated by changes in adolescents’ social environment, which becomes increasingly peer-dominated, and has an increasing presence of alcohol and cannabis use opportunities. While many youth continue to adulthood without consequence, the substance use patterns of many adolescents interfere with their academic progress, as well as their health, personal, and social development. This workshop presents an opportunity for us to explore the state of the art of adolescent addictions research, including current empirically supported interventions. In addition, this workshop includes hands-on experience practicing foundational skills in empirically supported intervention approaches (including motivational intervention and contingency management). Participants will depart with basic knowledge of, skills in, and resources to obtain further information in each clinical approach. Presenter: Sarah W. Feldstein Ewing, Ph.D., University of New Mexico, Honors College/Center on Alcoholism, Substance Abuse, and Addictions (CASAA) **This workshop provides 4 CE Credits and pre-registration is required.   POSTER SESSION   Last year’s poster session was the highlight of our networking events. This year, we will also be providing poster awards and inviting the first authors of select posters to present their research at our “Rapid Fire Research” sessions.  The priority deadline for poster submissions has passed, but poster proposals submitted prior to Nov. 30th will be considered.  For information on submitting, visit www.tinyurl.com/2014CPAPosters.   HOTEL/VENUE   The beautiful W Hotel in Midtown Atlanta will be the venue for our Annual Conference. The hotel is located in the heart of Midtown and is local to public transportation. Room rates are $159 per night. Reserve your room now!   MORE INFORMATION   Katie Witkiewitz, PhD, Co-Chair Jennifer Buckman, PhD, Co-Chair Jenna Cohen, Registration and Hotel Accommodations (202-682-5132)       *Continuing Education provided during the Collaborative Perspectives on Addiction Conference is provided by APA Division 50. APA Division 50 is approved by the American Psychological Association to sponsor continuing education for psychologists. Division 50 maintains responsibility for this program and its content. For more information on the available hours and learning objectives, contact jcohen@apa.org.

 

[DIV28SUPER] NIDA Neuroscience Update December 10, 2013

Table of contents

I.                    Grants Development and Technical Assistance Workshop for Early Stage Investigators, February 10-11, 2014 - Neuroscience Center, 6001 Executive Blvd, Rockville, MD

II.                  PAR-14-010  Identification of Gene Variants for Addiction Related Traits by Next-Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3)

III.                 PA-14-025  Discovering Novel Targets:  The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01)

IV.                Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Abuse (R21 and R01 FOAs)

V.                  Neuroscience Research on Drug Abuse (R03, R21, and R01 FOAs)

VI.                All NIDA Funding Opportunities Announcements

 

I. Grants Development and Technical Assistance Workshop for Early Stage Investigators, February 10-11, 2014 - Neuroscience Center, 6001 Executive Blvd, Rockville, MD

 

The National Institute on Drug Abuse (NIDA), Office of Diversity and Health Disparities will offer a Research Development Seminar Series Workshop (Part I) on February 10-11, 2014 for early stage investigators from underrepresented populations interested in applying for funding from NIDA.  The workshop will include information on funding opportunities, an overview of the grant review process, presentations from the NIDA research Divisions and Offices, and one-one-one meetings with program staff and grantees.  The application deadline is Friday, December 13^th.  For application instructions and additional information about this grant workshop opportunity please click on the following link:  NIDAseminarseries.

-----------------------------------

 

II. PAR-14-010  Identification of Gene Variants for Addiction Related Traits by Next-Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3)

 

Application due date(s):  January 31, 2014; June 30, 2014; October 31, 2014; June 30, 2015; October 31, 2015; June 30, 2016; by 5:00 PM local time of applicant organization.

 

The goals of this funding opportunity announcement are to: 1) develop strategies and methodologies for the sequencing, mapping and genomic analyzing of established phenotypes of selectively bred animal models with addiction traits, and 2) identify, from new or existing selectively bred animal models, genetic variants with implications for addiction related traits.  

-------------------

 

III. PA-14-025  Discovering Novel Targets:  The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01)

 

Application due date(s):  Standard dates apply, by 5:00 PM local time of applicant organization.

 

This FOA encourages applications for research projects that identify and/or validate chromosomal loci and variations in genes that are associated with vulnerability to addiction and that inform the likelihood of responsiveness to treatment.  Applications that propose to examine intermediate phenotypes or endophenotypes to assess the molecular genetics of drug addiction, addiction vulnerability and/or their associated co-morbidities and how they are related to drug addiction are especially encouraged.  Also encouraged are genetic as well as computational and large-scale genomic approaches, which may include but are not limited to linkage, linkage disequilibrium, case-control or family-based studies, and integration of data from other databases that may supplement substance abuse genetics and genomics data.  Data may be collected from the general population, special populations, recent admixed populations, and/or animal models. Secondary data analysis of data collected from the general population, special populations, recent admixed populations, and/or animal models is also appropriate for this announcement.  Investigators are encouraged to include, as a component of their project and as appropriate, gene x gene interactions, gene x environment interactions, gene x environment x development interactions, pharmacogenetics, and non-human models.

--------------------

 

IV. Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Abuse

PA-14-013 Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Abuse (R21)

PA-14-014  Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Abuse (R01)

 

Application Due Dates: Standard dates  apply, by 5:00 PM local time of applicant organization.

 

Genetic and genomic studies have identified genes and gene variants that potentially modulate the fundamental biological mechanisms underpinning addictive processes.  Discovery of these genes/variants, while extremely valuable, is only a first step in understanding molecular mechanisms of addiction. This Funding Opportunity Announcement encourages basic functional genetic and genomic research in two areas:  1. functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in addictive processes, and 2. detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction.

 ------------------------

 

V. Neuroscience Research on Drug Abuse

PA-13-336 Neuroscience Research on Drug Abuse (R03)

PA-13-337 Neuroscience Research on Drug Abuse (R21)

PA-13-338 Neuroscience Research on Drug Abuse  (R01)

 

Application Due Dates: Standard dates  apply, by 5:00 PM local time of applicant organization.

  

Substance abuse results in widespread changes in brain structure and function, and research is needed to explain these changes and how they affect behavior. The goals of the research areas described in this Neuroscience of Drug Abuse FOA are to understand the neurobiological mechanisms underlying drug abuse and addiction, with special emphasis on changes that occur during chronic drug use, withdrawal and relapse.  An understanding of the basic mechanisms underlying drug addiction can help to identify targets for prevention and treatment interventions. Research utilizing basic, translational, or clinical approaches is appropriate.

 

--------------------

 

VI. All NIDA Funding Opportunities Announcements

 

----------------

 

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to istserv@list.nih.govmailto:listserv@list.nih.gov,

 Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov     301-435-1309

 

[DIV28SUPER] NYTimes: The Case for Tolerating E-Cigarettes

http://nyti.ms/1iO6fmr

No one believes that nicotine addiction is good, but efforts are best spent on minimizing the resulting harm.


Sent from my iPad
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] Travel Award for CPDD 2014

There’s still time to apply for NIDA’s Women & Sex Gender Differences Research Travel Award for Junior Investigators for CPDD 2014!  CPDD extended their abstract submission deadline to Dec 10 (http://www.cpdd.vcu.edu/  ) so we also extended our application deadline to Dec 10!   For application details see the attached travel award announcement (or  click here for that announcement) or contact Dr. Samia Noursi (snoursi@mail.nih.gov; 301-594-5622) or me.  Please share this email with potential applicants. 

 

Thanks,

Cora Lee Wetherington

 

Cora Lee Wetherington, Ph.D.

Women & Sex/Gender Differences Research Coordinator

Division of Clinical Neuroscience & Behavioral Research

National Institute on Drug Abuse

6001 Executive Blvd., Suite 3155, MSC 9593

Bethesda, MD 20892-9593 (For overnight mail:  Rockville, MD 20852) 

Phone:  (301) 435-1319

Fax:  (301) 443-6814

E-mail: cwetheri@nida.nih.gov

 

NIDA’S WOMEN & SEX/GENDER DIFFERENCES JUNIOR INVESTIGATOR TRAVEL AWARD PROGRAM for CPDD 2014:       

Deadline has been extended to Dec 10!  See  http://www.drugabuse.gov/sites/default/files/files/CallforAbstracts2014CPDDwithextendeddeadline%281%29.pdf

 

Standard Due Dates: http://grants.nih.gov/grants/funding/submissionschedule.htm

 

 

 

 

 

[DIV28SUPER] Concurrent Session Lineup at the 2014 CPA Conference

Trouble viewing this email? Visit our Website 2014 Collaborative Perspectives on Addiction Atlanta, Georgia Feb. 28 - March 1, 2014 Reserve Your Hotel | Conference Registration | Present a Poster Download Registration Brochure CONCURRENT SESSIONS   We have a great lineup of concurrent sessions being offered at the CPA conference. See below for an overview or go to http://www.tinyurl.com/2014CPA to view full session descriptions.   The Effects of Social Influence on Substance Use Behavior and Outcomes in Preclinical and Clinical Samples Jodi Gilman, PhD; John F. Kelly, PhD; Allison Anacker, PhD   Working At the Crossroads: Clinical Findings from a Combined Medication and Psychotherapy Trial for Co-Occurring PTSD and AUD Denise Hien, PhD; Lesia M. Ruglass, PhD; Teresa Lopez-Castro, PhD; Laura Eidlitz, EdM; Annelisa Pedersen, MPhil; Patricia Yoon, MA   Opioid Overdose: Intervention Efforts and Challenges Kelly Dunn, PhD; Daniel Wermeling, PharmD; Maya Doe-Simkins, MPH; Dan Bigg, CRADC   Bringing Neuroscience Into Addiction Treatment Through Behavioral Interventions Marsha Bates, PhD; Brandon Alderman, PhD; David Eddie, MS; Tracey Shors, PhD; Edward Selby, PhD   Steps Toward Success As An Early Career Addiction Psychologist Katie Witkiewitz, PhD; John F. Kelly, PhD; Ellen Walker, PhD; Bill Stoops, PhD; James Murphy, PhD; James MacKillop, PhD; Lara Ray, PhD   Prescription Opioids: The Role of Efficacy, Pain Modalities, and Sex Differences in Reward States Ellen Walker, PhD; Sandra Comer, PhD   Enhancing Brief Alcohol Interventions Using Translational Research and Mechanisms of Change Approaches Ashley Dennhardt, PhD; Andrea R. Diulio, MS; Mark M. Silvestri, MS; James G. Murphy, PhD; Ali M. Yurasek, MS     ABOUT THE CONFERENCE   The theme for the 2014 CPA is "Changing Addictive Behavior: Bench to Bedside and Back Again" ·         Thought-provoking keynotes and cross-discipline panels ·         Interactive environment for collaboration/networking ·         Pre-Conference Workshop (see below) ·         Pre-Conference “Functional Integration” Session (see below) ·         Poster Sessions ·         Discounted rates for Early Career Psychologists ·         Student opportunities (discounted rates, special networking, etc.) ·         You don't have to be a member of either division or APA to attend the conference! ·         CE is available*!     HOTEL/VENUE   The beautiful W Hotel in Midtown Atlanta will be the venue for our Annual Conference. The hotel is located in the heart of Midtown and is local to public transportation. Room rates are $159 per night. Reserve your room now!   MORE INFORMATION   Katie Witkiewitz, PhD, Co-Chair Jennifer Buckman, PhD, Co-Chair Jenna Cohen, Registration and Hotel Accommodations (202-682-5132)       *Continuing Education provided during the Collaborative Perspectives on Addiction Conference is provided by APA Division 50. APA Division 50 is approved by the American Psychological Association to sponsor continuing education for psychologists. Division 50 maintains responsibility for this program and its content. For more information on the available hours and learning objectives, contact jcohen@apa.org.

 

 

[DIV28SUPER] FW: Call for Proposals; APF 2014 Visionary, Barlow, and Weiss Grants

 

 

From: Carney, Erin [mailto:ecarney@apa.org]
Sent: Thursday, December 05, 2013 12:45 PM
Subject: Call for Proposals; APF 2014 Visionary, Barlow, and Weiss Grants

 

Dear Sir or Madam:

 

You are receiving this message because you are an APA division listserv owner.  Please find attached the Call for Proposals for the following 2014 American Psychological Foundation (APF) grants:

 

Ø  Visionary Grants: Grants range from $5,000 - $20,000

Ø  David H. and Beverly A. Barlow Grant: One grant of up to $7,000

Ø  Drs. Rosalee G. and Raymond A. Weiss Research and Program Innovation Grant: One grant of up to $1,000

 

The deadline for all three programs is April 1, 2014.  Please consider publishing this announcement in your next message and feel free to distribute this call as you see fit at your organization.

 

Best,

 

Erin Carney

Program Coordinator

American Psychological Foundation

750 First Street, NE

Washington, DC 20002

P: (202) 336-5873 I F: (202) 336-5812 I ecarney@apa.org

www.americanpsychologicalfoundation.org

 

APF: Transforming the future through psychology